$BIIB news
The latest BIIB stock news: headlines, filings, AI summaries and sentiment for $BIIB, updated around the clock.
- Supernus Pharmaceuticals Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
- Stoke Therapeutics Reports Q3 2026 Financial Results and Clinical Pipeline Progress
- Biogen Reports Q3 2026 Revenue Growth Driven by Apellis Acquisition and Strong Growth Portfolio
- Biogen Reports Q3 Earnings Beat Driven by Multiple Sclerosis Franchise
- BIOGEN INC. - 10-Q Filing
- Biogen Reports Q3 Earnings Beat and Increases FY26 Financial Outlook
- BIOGEN INC. - 8-K Filing
- Market Outlook: Federal Reserve Interest Rate Decision and Key Earnings Reports
- Biogen Scheduled to Report Q3 2026 Earnings on October 28
- Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Therapy Access
- Midday Market Movers: eBay, Sandisk, Meta Platforms, IonQ, Lumentum Among Stocks Reacting to News
- Biggest Stock Movers on Monday Include CCC and BIIB
- JPMorgan Upgrades Biogen to Overweight with $300 Price Target on Strong Pipeline Catalysts in 2027
- Biogen's Litifilimab Shows Positive Long-Term Results in Cutaneous Lupus Trial
- Novo Nordisk Stock Falls After Outlining Long-Term Growth Targets
- Ionis Pharmaceuticals Stock Falls Over 40% This Year Despite Analysts' Bullish Outlook
- Biogen Advances Pipeline and Expands into Immunology and Nephrology
- Biogen Acquires RayThera to Bolster Immunology Portfolio Amid Shifting Financial Dynamics
- Veeva Systems Reports Strong Q2 Earnings and Raises Full-Year Guidance
- Eisai Reports Strong Q1 Financials and Updates FY2026 Outlook
- Biogen Reports Strong Q2 Revenue Growth, Drives Stock Performance
- Biogen Inc. Q2 2026 Earnings Call Summary
- Biogen Reports Strong Q2 Results, Exceeds Revenue and Earnings Expectations
- Biogen Stock Rises on Strong Q2 Performance
- Stocks Making Significant Moves Midday: Caterpillar, Vertiv, SoFi Technologies, AMD and Others
- Biogen Reports Q2 Revenue Growth Driven by Strong Performance of Growth Portfolio
- Premarket Stock Movements: Biogen, Vertiv, GE HealthCare and Others
- Biogen Exceeds Quarterly Estimates with Strong Performance from Newer Drugs
- BIOGEN INC. - 8-K Filing
- Biogen Shares Drop Following Mid-Stage Trial Results for Alzheimer’s Drug
- Biogen Shares Drop After Updated Data on Alzheimer's Drug Diranersen
- FDA Approves Subcutaneous Version of Biogen and Eisai's Alzheimer's Treatment Leqembi
- Energy Stocks Help Limit Dow Decline as Tech Slides Amid Geopolitical Tensions
- SK Hynix Drops 15% Amid Profit Estimate Concerns; Semiconductor Stocks Fall
- Energy Stocks Help Dow Amid Tech Slide Due to Geopolitical Tensions
- Stocks Making Significant Moves Midday: Nio, Braiin, AppLovin, SpaceX, SK Hynix
- Truist Upgrades Biogen to Buy Ahead of Alzheimer's Drug Data
- Stocks Making Significant Moves Midday: Moderna Surges Amid Strategy Update, On Semiconductor Slides on Acquisition
- International Regulatory Pathways Support Drug Development in Biotech and Pharma
- Healthcare Sector Headlines: Merck, Moderna, and Biogen in Focus
- Biogen Acquires RayThera for Up to $1 Billion
- Biogen Acquires RayThera for Up to $1 Billion
- Pomerantz Law Firm Investigates Biogen Inc. for Potential Securities Fraud
- Biogen and UCB Announce Positive Phase 3 Trial Results for Lupus Drug Dapirolizumab Pegol
- Biogen and Denali Discontinue Parkinson's Therapy BIIB122 After Mid-Stage Trial Setback
- Biogen Faces Securities Investigation by Pomerantz Law Firm Following Disappointing Alzheimer's Drug Trial Results
- Bright Horizons Family Solutions and Remitly Global to Join S&P SmallCap 600
- Supernus Reports Q1 2026 Earnings with Revenue Growth and Collaboration Revenues
- Bristol Myers Squibb's Earnings Highlight Legacy Portfolio Strength Amid Mixed Results
- Biogen Reports Strong Q1 Earnings Despite Guidance Cut